Knowledge about Human Papillomavirus and Time to Complete Vaccination among Vulnerable Female Youth - 24/03/16
, Lourdes Oriana Linares, PhD 1, Jocelyn Weiss, PhD, MPH 1, Nicolas F. Schlecht, PhD 2, 3, Viswanathan Shankar, DrPH 2, Debra Braun-Courville, MD 1, Anne Nucci-Sack, MD 1, Howard D. Strickler, MD, MPH 2, Robert D. Burk, MD 2, Angela Diaz, MD 1Abstract |
Objective |
To examine the association of knowledge about human papillomavirus (HPV) on the time to completion of the 3-dose quadrivalent vaccine series in an inner-city population of adolescent female subjects at high risk for infection.
Study design |
We prospectively followed 139 female subjects aged 14-20 years enrolled in a vaccine surveillance study in New York City during a period of at least 24 months. Participants were given a 30-item true or false survey on HPV at enrollment and ranked according to the number of correct responses. Multivariate Cox regression was used to examine the association between level of knowledge about HPV and time to completion (in days) of vaccine dose 1-3, dose 1-2, and dose 2-3.
Results |
Overall time to completion of the 3-dose vaccine ranged from 158 days to 1114 days. Participants in the high knowledge group (top quartile) were significantly more likely to complete the 3-dose series earlier (hazard ratio 1.69, 95% CI 1.03-2.77; P = .04), in particular doses 2-3 (hazard ratio 1.71, 95% CI 1.02-2.89; P = .04), than those with low-to-moderate knowledge (bottom 3 quartiles).
Conclusions |
These findings suggest that knowledge of HPV is associated with shorter time to complete the 3-dose HPV vaccine series. Educational campaigns at time of vaccination may be important to improve vaccine adherence.
Le texte complet de cet article est disponible en PDF.Keyword : HPV, SES, qHPV
Plan
| Funded by the National Institute of Allergy and Infectious Diseases (2RO1AI072204-06-AI). The authors declare no conflicts of interest. |
Vol 171
P. 122-127 - avril 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
